Transmedics Group Stock In The News
| TMDX Stock | USD 118.80 1.20 1.02% |
The overall news coverage of TransMedics Group from major news outlets shows bullish sentiment on 25 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of TransMedics' news coverage and content from conventional and social sources shows investors' bearish mood towards TransMedics Group. The specific impact of TransMedics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of TransMedics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using TransMedics headlines in addition to utilizing other, more conventional financial analysis modules. Check out TransMedics Backtesting and TransMedics Hype Analysis.
TransMedics |
TransMedics Today Top News and Investor Outlook
TransMedics Group Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide TransMedics and other traded companies coverage. We help investors stay connected with TransMedics headlines for the 2nd of May to make an informed investment decision based on correlating the impacts of news items on TransMedics Stock performance. Please note that trading solely based on the TransMedics Group hype is not for everyone as timely availability and quick action are needed to avoid losses.TransMedics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the TransMedics earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about TransMedics that are available to investors today. That information is available publicly through TransMedics media outlets and privately through word of mouth or via TransMedics internal channels. However, regardless of the origin, that massive amount of TransMedics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of TransMedics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of TransMedics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to TransMedics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive TransMedics alpha.
TransMedics Largest EPS Surprises
Earnings surprises can significantly impact TransMedics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-03-02 | 2019-12-31 | -0.39 | -0.43 | -0.04 | 10 | ||
2022-08-01 | 2022-06-30 | -0.35 | -0.41 | -0.06 | 17 | ||
2020-08-05 | 2020-06-30 | -0.42 | -0.36 | 0.06 | 14 | ||
2019-11-06 | 2019-09-30 | -0.45 | -0.39 | 0.06 | 13 | ||
2023-02-22 | 2022-12-31 | -0.3 | -0.21 | 0.09 | 30 | ||
2023-08-03 | 2023-06-30 | -0.13 | -0.03 | 0.1 | 76 |
TransMedics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to TransMedics Group Stock. Current markets are slightly bearish. About 56% of major world exchanges and indexes are down. See today's market update for more information.
30th of April 2024
TransMedics Beats Q1 Earnings and Revenue Estimates at zacks.com
25th of April 2024
Disposition of 2925 shares by Hassanein Waleed H of TransMedics at 74.06 subject to Rule 1... at zacks.com
23rd of April 2024
Should You Buy HCA Healthcare Ahead of Q1 Earnings at zacks.com
19th of April 2024
What Lies Ahead of IDEXX Laboratories in Q1 Earnings at zacks.com
18th of April 2024
TransMedics CEO sells 380,480 in stock, buys options at 13.28 at investing.com
17th of April 2024
Disposition of 4000 shares by Hassanein Waleed H of TransMedics at 95.12 subject to Rule 1... at Hassanein Waleed H
15th of April 2024
Theres Been No Shortage Of Growth Recently For TransMedics Groups Returns On Capital at finance.yahoo.com
12th of April 2024
Wall Street Favorites 3 Long-Term Stocks With Strong Buy Ratings for April 2024 at investorplace.com
10th of April 2024
Want Better Returns Dont Ignore These 2 Medical Stocks Set to Beat Earnings at zacks.com
9th of April 2024
Disposition of 8341 shares by Khayal Tamer I of TransMedics at 16.14 subject to Rule 16b-3 at Khayal Tamer I
8th of April 2024
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635 at finance.yahoo.com
4th of April 2024
Disposition of 2917 shares by Khayal Tamer I of TransMedics at 16.14 subject to Rule 16b-3 at Khayal Tamer I
1st of April 2024
Disposition of 15000 shares by Stephen Gordon of TransMedics at 74.01 subject to Rule 16b-... at Stephen Gordon
25th of March 2024
TRANSMEDICS GROUP Trade Ideas MUN8T8 TradingView - TradingView at news.google.com
4th of March 2024
Disposition of 15000 shares by Stephen Gordon of TransMedics at 82.8 subject to Rule 16b-3 at Stephen Gordon
1st of March 2024
TransMedics Group Price Target Raised to 105.00 at JPMorgan Chase Co. at thelincolnianonline.com
26th of February 2024
TransMedics Group Inc Reports Stellar Revenue Growth in Q4 and Full Year 2023 at gurufocus.com
23rd of February 2024
Acquisition by Hassanein Waleed H of 56645 shares of TransMedics at 83.14 subject to Rule ... at Hassanein Waleed H
21st of February 2024
Exercise or conversion by Sullivan John F of 9617 shares of TransMedics subject to Rule 16... at Sullivan John F
20th of February 2024
Disposition of 250 shares by Khayal Tamer I of TransMedics at 90.0 subject to Rule 16b-3 at Khayal Tamer I
15th of February 2024
Disposition of 776 shares by Khayal Tamer I of TransMedics at 16.0 subject to Rule 16b-3 at Khayal Tamer I
TransMedics Investors Sentiment
The influence of TransMedics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in TransMedics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to TransMedics' public news can be used to forecast risks associated with an investment in TransMedics. The trend in average sentiment can be used to explain how an investor holding TransMedics can time the market purely based on public headlines and social activities around TransMedics Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
TransMedics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for TransMedics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average TransMedics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on TransMedics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards TransMedics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, TransMedics' short interest history, or implied volatility extrapolated from TransMedics options trading.
Check out TransMedics Backtesting and TransMedics Hype Analysis. Note that the TransMedics Group information on this page should be used as a complementary analysis to other TransMedics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for TransMedics Stock analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is TransMedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TransMedics. If investors know TransMedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TransMedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share 7.431 | Quarterly Revenue Growth 1.587 | Return On Assets 0.0006 | Return On Equity (0.15) |
The market value of TransMedics Group is measured differently than its book value, which is the value of TransMedics that is recorded on the company's balance sheet. Investors also form their own opinion of TransMedics' value that differs from its market value or its book value, called intrinsic value, which is TransMedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TransMedics' market value can be influenced by many factors that don't directly affect TransMedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TransMedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if TransMedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TransMedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.